Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Low Body Mass Index as a Risk Factor for Antiretroviral Drug-Related Liver Injury Among HIV Patients

ACTA MEDICA INDONESIANA · Vol. 51 No. 3 (2019)

ISSN
2338-2732, 0125-9326
Terbit
2019-11-07
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Background: antiretroviral drug-related liver injury (ARLI) is a drug-induced hepatotoxicity due to antiretroviral medication (ARV). It commonly disrupts compliance to treatment and causes treatment discontinuation in HIV-infected patients. Several studies have been conducted on predisposing factors for ARLI including studies on body mass index (BMI) and cluster of differentiation 4 (CD4). The association of BMI and CD4 with ARLI remains controversial as previous studies have demonstrated different outcomes. Our study was conducted to identify the association of low baseline BMI and CD4 cell count as risk factors for ARLI in HIV-infected patients. Methods: this is a cross-sectional study. Subjects were 75 patients with HIV-AIDS who received ARV therapy using fixed-dose combination (tenofovir, lamivudine, efavirenz) at the Teratai HIV outpatient clinic of Hasan Sadikin Hospital in Bandung city. Alanine aminotransferase (ALT) test was performed prior to starting ARV treatment and the test was repeated on the sixth month of therapy. Results: there was no significant difference on the proportion of low baseline CD4 count between ARLI and non-ARLI group (p=0.155). Bivariate analysis demonstrated that regarding the proportion of low baseline BMI, there was a significant difference between ARLI and non-ARLI group (p= 0.001). Multivariate analysis using logistic regression showed that BMI of < 18.5 kg/m2 increased the risk for developing ARLI by 5.53 fold; while CD4 cell count of < 200 cells/µL did not the risk. Conclusion: our study indicates that low baseline BMI may increase the risk for developing ARLI; while low baseline CD4 cell count does not; therefore, we suggest that ALT test should be performed on a routine basis among HIV-AIDS patients for early detection of ARLI, particularly in patients with low BMI.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 245 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Rianita JuniatiAfiliasi tidak diketahui1
Rudi WisaksanaAfiliasi tidak diketahui1
Ida ParwatiAfiliasi tidak diketahui1
Prayudi SantosoAfiliasi tidak diketahui1
Arto Y SoerotoAfiliasi tidak diketahui1
Bachti AlisjabanaAfiliasi tidak diketahui1
Heda M NataprawiraAfiliasi tidak diketahui1
Arto Yuwono SoerotoAfiliasi tidak diketahui1
Jipi E PerkusiAfiliasi tidak diketahui1
Ferdy FerdianAfiliasi tidak diketahui1
Undang RehimatAfiliasi tidak diketahui1
Hendarsyah SuryadinataAfiliasi tidak diketahui1
Rini R BachtiarAfiliasi tidak diketahui1
Irsan HasanAfiliasi tidak diketahui1
Juferdy KurniawanAfiliasi tidak diketahui1
Fauzi YusufAfiliasi tidak diketahui1
Syifa MustikaAfiliasi tidak diketahui1
Ulfa KholiliAfiliasi tidak diketahui1
Fandy GosalAfiliasi tidak diketahui1
Gita ApriliciaAfiliasi tidak diketahui1
Hery Djagat PurnomoAfiliasi tidak diketahui1
Cecilia O PermatawediAfiliasi tidak diketahui1
Tehar Karo-KaroAfiliasi tidak diketahui1
Haris WiditaAfiliasi tidak diketahui1
Aritantri DarmayaniAfiliasi tidak diketahui1
Arif Nur WidodoAfiliasi tidak diketahui1
Saptino MiroAfiliasi tidak diketahui1
Suyata SuyataAfiliasi tidak diketahui1
Catharina TriwikatmaniAfiliasi tidak diketahui1
I Ketut MariadiAfiliasi tidak diketahui1
Indra WijayaAfiliasi tidak diketahui1
Bethy S HernowoAfiliasi tidak diketahui1
Laniyati HamijoyoAfiliasi tidak diketahui1
Dinar F YaddinAfiliasi tidak diketahui1
Panji Irani FianzaAfiliasi tidak diketahui1
Hermin Aminah UsmanAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Low Body Mass Index as a Risk Factor for Antiretroviral Drug-Related Liver Injury Among HIV Patients</dc:title>
	<dc:creator>Budiman, Benny</dc:creator>
	<dc:creator>Hartantri, Yovita</dc:creator>
	<dc:creator>Susandi, Evan</dc:creator>
	<dc:creator>Agustanti, Nenny</dc:creator>
	<dc:subject xml:lang="en-US">antiretroviral drug-related liver injury (ARLI)</dc:subject>
	<dc:subject xml:lang="en-US">body mass index (BMI)</dc:subject>
	<dc:subject xml:lang="en-US">cluster of differentiation 4 (CD4)</dc:subject>
	<dc:description xml:lang="en-US">Background: antiretroviral drug-related liver injury (ARLI) is a drug-induced hepatotoxicity due to antiretroviral medication (ARV). It commonly disrupts compliance to treatment and causes treatment discontinuation in HIV-infected patients. Several studies have been conducted on predisposing factors for ARLI including studies on body mass index (BMI) and cluster of differentiation 4 (CD4). The association of BMI and CD4 with ARLI remains controversial as previous studies have demonstrated different outcomes. Our study was conducted to identify the association of low baseline BMI and CD4 cell count as risk factors for ARLI in HIV-infected patients. Methods: this is a cross-sectional study. Subjects were 75 patients with HIV-AIDS who received ARV therapy using fixed-dose combination  (tenofovir, lamivudine, efavirenz) at the Teratai HIV outpatient clinic of Hasan Sadikin Hospital in Bandung city. Alanine aminotransferase (ALT) test was performed prior to starting ARV treatment and the test was repeated on the sixth month of therapy. Results: there was no significant difference on the proportion of low baseline CD4 count between ARLI and non-ARLI group (p=0.155). Bivariate analysis demonstrated that regarding the proportion of low baseline BMI, there was a significant difference between ARLI and non-ARLI group (p= 0.001). Multivariate analysis using logistic regression showed that BMI of &amp;lt; 18.5 kg/m2 increased the risk for developing ARLI by 5.53 fold; while CD4 cell count of &amp;lt; 200 cells/µL did not the risk. Conclusion: our study indicates that low baseline BMI may increase the risk for developing ARLI; while low baseline CD4 cell count does not; therefore, we suggest that ALT test should be performed on a routine basis among HIV-AIDS patients for early detection of ARLI, particularly in patients with low BMI.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2019-11-07</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/871</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 51 No. 3 (2019): Acta Medica Indonesiana; 214</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/871/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>